首頁 > 市場調查報告書 > 醫療設備

導管

血管移植物市場規模、佔有率和成長分析（按產品、原料、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902069

血管移植物市場規模、佔有率和成長分析（按產品、原料、應用、最終用戶和地區分類）－2026-2033年產業預測

Vascular Grafts Market Size, Share, and Growth Analysis, By Product (Hemodialysis Access Grafts, Endovascular Stent Grafts), By Raw Material, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球血管移植物市場規模將達到 16 億美元，到 2025 年將達到 17.2 億美元，到 2033 年將達到 29.9 億美元，在預測期（2026-2033 年）內，複合年成長率為 7.2%。

心血管疾病發生率的上升預計將成為推動全球血管移植市場成長的主要因素。糖尿病和高血壓等疾病的併發症預計也將促進對血管移植的需求成長。此外，全球人口老化為該行業的公司提供了巨大的機會。微創手術日益普及預計將進一步改善血管移植供應商的前景。然而，該市場也面臨許多挑戰，包括手術併發症的風險、來自其他治療方法的競爭以及熟練血管外科醫生的短缺，這些因素可能會隨著時間的推移阻礙行業的成長。總體而言，儘管存在這些潛在障礙，血管移植市場仍呈現擴張的跡象。

全球血管移植市場促進因素

全球血管移植市場受不健康生活方式和不良習慣導致的心血管疾病發生率上升的推動。動脈粥狀硬化、冠狀動脈疾病和周邊動脈疾病等疾病日益普遍，需要進行血管修復手術和外科介入。隨著醫療保健系統積極應對這一不斷成長的需求，血管移植的使用量顯著增加。心血管健康問題的激增凸顯了對有效治療方法的迫切需求，從而推動了血管移植在醫療保健市場的成長前景。

限制全球血管移植市場發展的因素

全球血管移植市場面臨嚴峻挑戰，因為該市場高度依賴技術精湛的外科醫生才能成功完成手術。血管移植手術需要專業的知識，這導致全球合格的血管外科醫生嚴重短缺。這種人才短缺會降低整體手術成功率，並導致患者預後不佳。因此，熟練外科醫生的數量直接影響血管移植在臨床實踐中的應用和療效，並可能阻礙血管移植市場的預期成長。這種人才短缺有可能阻礙這一重要醫學領域的發展。

全球血管移植市場趨勢

全球血管移植市場正呈現出生物工程血管移植廣泛應用的顯著趨勢。這些移植血管能夠高度模擬活體血管的功能，同時最大限度地降低傳統血管移植方式相關的感染和免疫排斥風險。生物可吸收材料和再生醫學的創新正在推動這項變革，為產業內的新興企業企業和成熟企業創造了許多機會。這種轉變不僅改善了患者的治療效果，也與日益成長的以患者為中心的先進外科解決方案的需求相吻合，預示著血管移植技術在醫療保健領域正迎來變革性的發展方向。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

WL Gore & Associates, Inc.（US）
Medtronic plc（Ireland）
Cook Medical（US）
Terumo Medical Corporation（Japan）
B. Braun Melsungen AG（Germany）
Getinge AB（Sweden）
CryoLife, Inc.（US）
Cardinal Health（Cordis）（US）
Abbott Laboratories（US）
Endologix Inc.（US）
Vascular Graft Solutions Ltd.（Israel）
Heart Medical Europe BV（Netherlands）
Maquet（Getinge Group）（Germany）
BD（Becton, Dickinson and Company）（US）
Vascudyne, Inc.（US）
VASCULAR GENESIS
BIOVIC Sdn Bhd（Malaysia）

結論與建議

簡介目錄

Product Code: SQMIG35A2177

Global Vascular Grafts Market size was valued at USD 1.6 Billion in 2024 and is poised to grow from USD 1.72 Billion in 2025 to USD 2.99 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).

The escalating incidence of cardiovascular diseases is set to be a key driver for growth in the global vascular grafts market. Complications arising from conditions such as diabetes and hypertension are likely to boost demand for vascular grafts. Additionally, the rising elderly population worldwide offers significant opportunities for companies in this sector. The increasing preference for minimally invasive surgical procedures is expected to further enhance prospects for vascular graft providers. However, the market faces challenges, including the risk of complications associated with procedures, competition from alternative treatments, and a shortage of skilled vascular surgeons, which may hinder industry growth over time. Overall, the vascular grafts market is poised for expansion despite these potential obstacles.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vascular Grafts market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vascular Grafts Market Segments Analysis

Global Vascular Grafts Market is segmented by Product, Raw Material, Application, End User and region. Based on Product, the market is segmented into Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease and Peripheral Vascular Grafts. Based on Raw Material, the market is segmented into Synthetic Vascular Grafts, Biological Vascular Grafts and Hybrid Vascular Grafts. Based on Application, the market is segmented into Cardiac Aneurysm, Kidney Failure, Vascular Occlusion and Coronary Artery Disease. Based on End User, the market is segmented into Hospitals and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Vascular Grafts Market

The Global Vascular Grafts market is being propelled by the rising prevalence of cardiovascular diseases linked to poor lifestyle choices and the adoption of unhealthy habits among populations. Conditions like atherosclerosis, coronary artery disease, and peripheral artery disease are becoming increasingly common, necessitating vascular repair procedures and surgical interventions. As healthcare systems respond to this growing demand, the usage of vascular grafts is seeing a notable increase. This surge in cardiovascular health issues highlights the critical need for effective treatment options, thereby enhancing the growth prospects for vascular grafts in the medical market.

Restraints in the Global Vascular Grafts Market

The global vascular grafts market faces significant challenges due to the reliance on highly skilled surgeons for successful procedures. The need for expertise in performing vascular grafting highlights a critical issue: the persistent shortage of qualified vascular surgeons worldwide. This scarcity can impede the overall success rates of these procedures, potentially leading to reduced patient outcomes. As a result, the anticipated growth of the vascular grafts market may be hindered, as the availability of proficient surgical professionals directly impacts both the adoption and effectiveness of vascular grafts in medical practice. This talent gap could stall advancements in this important healthcare segment.

Market Trends of the Global Vascular Grafts Market

The Global Vascular Grafts market is witnessing a significant trend towards the development of bioengineered vascular grafts, which closely replicate the functionality of native blood vessels while minimizing the risks of infection and immune rejection associated with traditional options. Innovations in bioresorbable materials and regenerative medicine are driving this evolution, paving the way for an array of opportunities for both emerging and established players within the industry. This shift not only enhances patient outcomes but also aligns with the growing demand for advanced, patient-centered surgical solutions, suggesting a transformative direction for vascular graft technologies in the healthcare landscape.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Vascular Grafts Market Size by Product & CAGR (2026-2033)

Market Overview
Hemodialysis Access Grafts
Endovascular Stent Grafts
- Abdominal Aortic Aneurysms Repair
- Thoracic Aortic Aneurysm Repair
Coronary Artery By-Pass Grafts
Vascular Grafts for Aorta Disease
Peripheral Vascular Grafts

Global Vascular Grafts Market Size by Raw Material & CAGR (2026-2033)

Market Overview
Synthetic Vascular Grafts
- Polytetrafluoroethylene (PTFE) Grafts
- Polyester Grafts
- Polyurethane Grafts
Biological Vascular Grafts
- Autografts
- Allografts
- Xenografts
Hybrid Vascular Grafts

Global Vascular Grafts Market Size by Application & CAGR (2026-2033)

Market Overview
Cardiac Aneurysm
- Endovascular Stent Graft
- Vascular Graft
Kidney Failure
Vascular Occlusion
Coronary Artery Disease

Global Vascular Grafts Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Ambulatory Surgical Centers

Global Vascular Grafts Market Size & CAGR (2026-2033)

North America (Product, Raw Material, Application, End User)
- US
- Canada
Europe (Product, Raw Material, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Raw Material, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Raw Material, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Raw Material, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

W. L. Gore & Associates, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Medical Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CryoLife, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (Cordis) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endologix Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascular Graft Solutions Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heart Medical Europe BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maquet (Getinge Group) (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vascudyne, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VASCULAR GENESIS
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOVIC Sdn Bhd (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments